Compare

Ernexa Therapeutics Inc. vs CDT Equity Inc. vs AEON Biopharma, Inc. vs Aethlon Medical Inc

Latest annual figures from SEC filings. Each company is shown for its own most recent fiscal year, so period ends can differ. Select a figure to see its full history.

Latest fiscal yearErnexa Therapeutics Inc.
ERNA
CDT Equity Inc.
CDT
AEON Biopharma, Inc.
AEON
Aethlon Medical Inc
AEMD
Year ended2025-12-312025-12-312025-12-312026-03-31
Revenuen/an/an/an/a
Revenue growth (YoY)n/an/an/an/a
Gross marginn/an/an/an/a
Operating marginn/an/an/an/a
Net marginn/an/an/an/a
Net income-$14.08M-$39.22M-$39.22M-$7.15M
EPS (Diluted)-$2.24-$1177.89-$3.95-$10.61
Operating cash flow-$7.02M-$15.55M-$17.31M-$7.00M
Free cash flow-$7.05Mn/a-$17.31M-$7.00M
Cash & equivalentsn/a$1.51M$3.01M$5.03M
Total assets$5.83M$5.65M$5.56M$6.33M
Total liabilities$3.43M$12.82M$60.59M$1.45M
Shareholders' equity$2.40M-$7.17M-$55.03M$4.89M
Return on year-end equity-586.6%n/an/a-146.4%
Shares outstanding7.85M92.1K12.11M1.57M

n/a means the company did not report that line under the concept TickerFacts maps, not that it is zero.

Revenue, most recent five fiscal years

Fiscal yearErnexa Therapeutics Inc.CDT Equity Inc.AEON Biopharma, Inc.Aethlon Medical Inc
Latest$582.0K
Ended 2024-12-31
n/an/a$0
Ended 2024-03-31
1 year earlier$68.0K
Ended 2023-12-31
n/an/a$574.2K
Ended 2023-03-31
2 years earlier$0
Ended 2022-12-31
n/an/a$294.2K
Ended 2022-03-31
3 years earliern/an/an/a$659.1K
Ended 2021-03-31
4 years earlier$5.80M
Ended 2020-12-31
n/an/a$650.2K
Ended 2020-03-31